Dycom’s Revenue Mirage: Record EPS Masks a Shocking $370M Sales Collapse

The Lede and the Real Story

On the surface, Dycom Industries’ fiscal second-quarter 2027 earnings call was a victory lap. Management touted “record revenue,” a “robust backlog,” and raised full-year guidance. The headline numbers seemed to support the narrative: earnings per share of $5.29 crushed analyst estimates of $4.72 by a stunning 12.2%. But a skeptical eye on the actual figures reveals a far more troubling story. Revenue came in at $1.61 billion — a staggering 18.8% below the $1.98 billion analysts expected. This is not a minor miss; it is a catastrophic top-line shortfall that management buried under the EPS beat.

The real story is the yawning chasm between reported profitability and actual business volume. In the previous quarter (Q1 FY2027), Dycom reported revenue of $1.96 billion. The latest quarter’s $1.61 billion represents a sequential collapse of $350 million, or roughly 18%. This is not a seasonal dip; it is a demand cliff. Management’s prepared remarks focused on margin expansion and backlog strength, but they conspicuously avoided dissecting the quarter-over-quarter revenue implosion. The stock market’s reaction was telling: shares plunged 11.62% in after-hours trading, wiping out $40.89 of value per share. The market is not buying the spin. The tension here is between an EPS number inflated by cost-cutting and acquisition accounting, and a core business that is rapidly shrinking.